| Trial ID: | L6754 |
| Source ID: | NCT00177398
|
| Associated Drug: |
Glargine Insulin Vs Regular Insulin
|
| Title: |
Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Hyperglycemia
|
| Interventions: |
DRUG: Glargine insulin vs regular insulin
|
| Outcome Measures: |
Primary: The primary outcome to be studied is the frequency and severity of hyperglycemia and hypoglycemia in each group|Time to mean 24 hour plasma glucose < 180 mg/dl | Secondary: Triglyceride level at study entry and conclusion|Hospital length of stay|Inpatient mortality|Number of days of antibiotic therapy|Number of days with recorded temperature >/= 100.4F|Occurrence of any of the following: MI, CHF, pneumonia, CVA, renal impairment (defined as serum creat > 2 mg/dl)|Quality of Life measures using MOS SF 36 General Health Survey|Outpatient glycemic control and self management practices
|
| Sponsor/Collaborators: |
Sponsor: University of Pittsburgh | Collaborators: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-02
|
| Completion Date: |
2006-08
|
| Results First Posted: |
|
| Last Update Posted: |
2007-12-19
|
| Locations: |
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00177398
|
